FTO Gene Variant Is Associated with Obesity: Longitudinal Analyses in Two Cohort Studies and Functional Test

Abstract Objective: To examine the longitudinal association of FTO variant with obesity, circulating adipokine levels, and FTO expression in various materials from human and mouse. Research Design and Methods: We genotyped rs9939609 in 2,287 men and 3,520 women from two prospective cohorts. Plasma adiponectin and leptin were measured in a subset of diabetic men (n=854) and women (n=987). Expression of FTO was tested in adipocytes from db/db mice and mouse macrophages. Results: We observed a trend toward decreasing associations between rs9939609 and BMI at older age (≥65 y) in men, whereas the associations were constant across different age groups in women. In addition, SNP rs9939609 was associated with lower plasma adiponectin [log(e)- means: 1.82±0.04, 1.73±0.03, and 1.68±0.05 for TT, TA, and AA genotypes; P for trend=0.02] and leptin (log(e)- means: 3.56±0.04, 3.63±0.04, and 3.70±0.06; P for trend=0.06] in diabetic women. Adjustment for BMI attenuated the associations. FTO gene was universally expressed in human and mice tissues, including adipocytes. In an ancillary study of adipocytes from db/db mice, FTO expression was ∼50% lower than those from wild-type mice. Conclusions: The association between FTO SNP rs9939609 and obesity risk may decline at older age. The variant affects circulating adiponectin and leptin levels through the changes in BMI. In addition, the expression of FTO gene was reduced in adipocytes from db/db mice.

[1]  T. Wong,et al.  FTO Variants Are Associated With Obesity in the Chinese and Malay Populations in Singapore , 2008, Diabetes.

[2]  L. V. Van Gaal,et al.  Variants in the FTO gene are associated with common obesity in the Belgian population. , 2008, Molecular genetics and metabolism.

[3]  C. Magness,et al.  Association of the FTO Gene With BMI , 2008, Obesity.

[4]  Yusuke Nakamura,et al.  Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 With Susceptibility to Type 2 Diabetes in a Japanese Population , 2008, Diabetes.

[5]  T. Hansen,et al.  Low Physical Activity Accentuates the Effect of the FTO rs9939609 Polymorphism on Body Fat Accumulation , 2008, Diabetes.

[6]  Hongyu Zhao,et al.  FTO gene SNPs associated with extreme obesity in cases, controls and extremely discordant sister pairs , 2008, BMC Medical Genetics.

[7]  Harald Grallert,et al.  Genome Wide Association (GWA) Study for Early Onset Extreme Obesity Supports the Role of Fat Mass and Obesity Associated Gene (FTO) Variants , 2007, PloS one.

[8]  P. Scifo,et al.  Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation. , 2007, The Journal of clinical endocrinology and metabolism.

[9]  Chris P. Ponting,et al.  The Obesity-Associated FTO Gene Encodes a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase , 2007, Science.

[10]  F. Hu,et al.  Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  M. McCarthy,et al.  Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes , 2007, Science.

[12]  Beverley Balkau,et al.  Variation in FTO contributes to childhood obesity and severe adult obesity , 2007, Nature Genetics.

[13]  G. Abecasis,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.

[14]  James Strait,et al.  Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits , 2007, PLoS genetics.

[15]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[16]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[17]  J. Manson,et al.  Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. , 2006, Human molecular genetics.

[18]  E. Mannarino,et al.  The endocrine function of adipose tissue: an update , 2006, Clinical endocrinology.

[19]  J. Manson,et al.  HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women. , 2005, Diabetes.

[20]  J. Manson,et al.  Adiposity as compared with physical activity in predicting mortality among women. , 2005, The New England journal of medicine.

[21]  Geetha R. Soodini.  Adiponectin and leptin in relation to insulin sensitivity. , 2004, Metabolic syndrome and related disorders.

[22]  Nader Rifai,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[23]  Cynthia J. Girman,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[24]  Nader Rifai,et al.  Inflammatory markers and risk of developing type 2 diabetes in women. , 2004, Diabetes.

[25]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[26]  William A. Boisvert,et al.  Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ , 2003, Science.

[27]  J. Engel,et al.  Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin , 2003, The Journal of Biological Chemistry.

[28]  H. Boeing,et al.  Adiponectin and protection against type 2 diabetes mellitus , 2003, The Lancet.

[29]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[30]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[31]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[32]  Anson,et al.  DIET , LIFESTYLE , AND THE RISK OF TYPE 2 DIABETES MELLITUS IN WOMEN , 2001 .

[33]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[34]  F. Rank,et al.  PRIMARY PREVENTION OF CORONARY HEART DISEASE IN WOMEN THROUGH DIET AND LIFESTYLE , 2000 .

[35]  B. Everitt,et al.  Analysis of longitudinal data , 1998, British Journal of Psychiatry.

[36]  J. Manson,et al.  The Nurses' Health Study: 20-year contribution to the understanding of health among women. , 1997, Journal of women's health.

[37]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[38]  D. Carmelli,et al.  Evidence for independent genetic influences on obesity in middle age. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[39]  A. Rissanen,et al.  Effects of gender and age on the heritability of body mass index. , 1991, International journal of obesity.

[40]  E. Rimm,et al.  Prospective study of alcohol consumption and risk of coronary disease in men , 1991, The Lancet.

[41]  B Rosner,et al.  A prospective study of obesity and risk of coronary heart disease in women. , 1990, The New England journal of medicine.

[42]  A. Stunkard,et al.  A twin study of human obesity. , 1986, JAMA.

[43]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[44]  W. Willett,et al.  Cigarette smoking, relative weight, and menopause. , 1983, American journal of epidemiology.

[45]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.